Patients For Affordable Drugs NOW

P4ADNow is a bipartisan patient advocacy organization fighting for lower drug prices. We mobilize patients in support of legislation to fix our broken system.

[Patients For Affordable Drugs NOW @P4ADNOW]

P4ADNOW’s Executive Director, @GlobalDiaBEATes, breaks down how Big Pharma games the patent system to keep prices and profits high, and how we are working to stop patent abuse to ensure more competition in the drug market and lower drug costs. Be part of this fight because together we can win. https://t.co/tAdSJoU7wP

[Patients For Affordable Drugs NOW @P4ADNOW]

P4AD Town Hall https://t.co/eqtN5y5Q5h

[Senator Peter Welch @SenPeterWelch]

It's time we rein in Big Pharma's abuse of the patent system.

That’s why my colleagues should join my bill with @SenAmyKlobuchar and @SenHawleyPress so we can get more affordable generics on the market and save patients money at the pharmacy counter.

[Patients For Affordable Drugs NOW @P4ADNOW]

Congress is hearing from Big Pharma lobbyists right now. The question is whether they’ll also hear from you...

Recently, patient advocates from across the country flew to D.C. to sit across from lawmakers and deliver a clear message: pass the ETHIC Act.

One of them was Maureen, who traveled from Florida. She’d never done anything like this before. She walked into those meetings not knowing what to expect — just knowing she had to try. "These people work for us," she said after. "If we don't try, we might as well throw in the towel."

Now it's our job to back her up.

Contact your representative about supporting the ETHIC Act today: https://t.co/H5Fnmceb1V

[Patients For Affordable Drugs NOW @P4ADNOW]

💯 Big Pharma's abuse of the patent system doesn't just affect patients, it's causing harm to families and communities and must be stopped.

The ETHIC Act would reduce drug company patent abuse by addressing double patenting but Big Pharma's lobbyists are hard at work against it.

Fight back against Big Pharma greed! Send a letter to your representative urging them to put patients first by supporting the ETHIC Act today: https://t.co/H5Fnmceb1V

[Patients For Affordable Drugs NOW @P4ADNOW]

NUEVO VIDEO: Acabamos de lanzar un nuevo video que explica uno de los factores más importantes — y menos discutidos — detrás de los altos precios de los medicamentos: el abuso del sistema de patentes. El proyecto de Ley ETHIC cerraría algunas de las estrategias que las compañias farmacéuticas explotan para bloquear la entrada de versiones genéricas más asequibles. Míralo, compártelo y pide al Congreso que actúe: https://t.co/FEICq9VDjD

[Patients For Affordable Drugs NOW @P4ADNOW]

NEW VIDEO: We just released a new video explaining one of the most important — and least talked about — drivers of high drug prices: patent abuse. The ETHIC Act would close the loopholes drug companies exploit to block cheaper generics. Watch, share, and urge Congress to act: https://t.co/CRR9ojek4E

[Patients For Affordable Drugs NOW @P4ADNOW]

Si quieres tener la oportunidad de viajar a Washington D.C. para compartir tu historia con los altos precios de los medicamentos recetados, únete a la comunidad de P4AD. Es importante que tus legisladores escuchen tu historia. Comparte tu historia hoy: https://t.co/dX2vigKYzi

[Patients For Affordable Drugs NOW @P4ADNOW]

Patients like Kris Garcia know that drug pricing reforms like the ETHIC Act are more than policy; they’re about real people finally getting relief from predatory drug pricing practices.

Thank you to @EpochTimes for uplifting patient voices and the urgent need for Congress to pass the ETHIC Act.

Join Kris in speaking out against Big Pharma greed by sending a letter to your rep in support of the ETHIC Act today: https://t.co/H5Fnmceb1V

[Patients For Affordable Drugs NOW @P4ADNOW]

Drug companies point the finger at PBMs but the root of high drug prices are the high list prices set by the drug companies themselves. Learn how P4ADNOW is fighting back at https://t.co/kZhQNl9HhE

[Patients For Affordable Drugs NOW @P4ADNOW]

Las farmacéuticas de marca están manipulando el sistema de patentes para mantener altos los precios de los medicamentos, y los pacientes están enfrentando dificultades. Aprende más sobre la _maraña de patentes_ y otras prácticas de la gran industria farmacéutica en https://t.co/4hOgYgxi0M en el enlace de nuestra biografía.

[Patients For Affordable Drugs NOW @P4ADNOW]

The bipartisan Eliminating Thickets to Improve Competition (ETHIC) Act would give patients faster access to more affordable prescription drugs but Big Pharma is lobbying against it to protect their profits. Make sure they don’t get their way -- send a letter to your representative urging them to put patients first by supporting ETHIC today: https://t.co/H5Fnmceb1V

[Patients For Affordable Drugs NOW @P4ADNOW]

Use your voice to help change policy! Share your story with P4ADNOW: https://t.co/MUix7rpW7B

¡Usa tu voz para cambiar las políticas! Comparte tu historia con P4ADNOW: https://t.co/dX2vigKYzi

[Patients For Affordable Drugs NOW @P4ADNOW]

The ETHIC Act would reduce drug company patient abuse by addressing duplicative patenting but Big Pharma's lobbyists are hard at work against it.

Help us fight Big Pharma greed. Send a letter to your representative urging them to put patients first by supporting the ETHIC Act today: https://t.co/H5Fnmceb1V

[Patients For Affordable Drugs NOW @P4ADNOW]

Polling from @KFF reveals about 43% of adults in the US have skipped, rationed, or gone without a prescription drug due to cost in the past year. At Patients For Affordable Drugs, we believe that no one should have to make the impossible choice between the medications they need to live and other bills. Visit https://t.co/WNxaz1SlIo to learn more and join the fight for lower prescriptions drug prices.

[Patients For Affordable Drugs NOW @P4ADNOW]

When Big Pharma games the patent system, patients pay the price but there are bipartisan bills in Congress that are smart, practical steps to lower prescription drug prices.

By strengthening coordination between the U.S. Patent and Trademark Office (USPTO) and the U.S. Food and Drug Administration (FDA), we could ensure fewer opportunities for patent manipulation, more transparency in how patents are granted and enforced, and faster access to affordable medications for patients.

Americans shouldn’t have to pay more because of bureaucratic silos. Let's ensure the system works for people, not just pharmaceutical companies.

[Patients For Affordable Drugs NOW @P4ADNOW]

Patents could keep an Ozempic generic off the U.S. market until at least 2031, reintroduced legislation would forbid large health care companies that own PBMs from directly owning pharmacies, and tariffs are reshaping how companies operate, but not addressing the root causes of high drug prices. Read more at our Week in Review: https://t.co/BSZsox9aGf

[Patients For Affordable Drugs NOW @P4ADNOW]

Kris Garcia, un Defensor de Pacientes de P4AD, paga $10,000 al mes por sus medicamentos. Debibo a esto, Kris ha tenido que tomar decisiones muy dificiles para asegurarse de que pueda seguir sano. Si tu o alguien que conoces tiene una historia personal con el alto costo de los medicamentos recetados, comparte tu historia con P4AD: https://t.co/RjHDDMdddf

[Patients For Affordable Drugs NOW @P4ADNOW]

Brand-name drug companies are manipulating the patent system to keep generics off the market. This ensures drug prices stay high while patients struggle to afford them. Learn more about patent thickets and other Big Pharma schemes at https://t.co/hIEVRvecMQ

[Patients For Affordable Drugs NOW @P4ADNOW]

P4AD patient advocate Jackie relies on the 2022 prescription drug law's $2,000 cap on out of pocket costs to afford the medication she needs to survive. To learn more about the 2022 prescription drug law and how it's helping patients save money at the pharmacy, visit https://t.co/IqGN4WE2mm

[Patients For Affordable Drugs NOW @P4ADNOW]

According to a recent @KFF poll, 30% of Hispanic adults and 24% of Black adults in the US say they are very worried about being able to afford prescription medications for themselves or their families.

For many families from these marginalized communities, concerns about the cost of medication go far beyond a single pharmacy trip and can lead to rationing and delaying medications or choosing not to fill a prescription at all.

While recent reforms have helped lower out-of-pocket costs for patients on Medicare in particular, there are still too many families who are struggling to afford the medications they need. There are bipartisan bills in Congress that would lower drug prices for patients, learn more at: https://t.co/mmecgTfbPT